The Philippines’ food and drug agency said on Friday it has approved the emergency use of the COVID-19 vaccine developed by Indian company Bharat Biotech.
Bharat Biotech has received “full emergency use authorisation” for its Covaxin brand after the company completed documentary requirements,” Food and Drug Administration chief Rolando Enrique Domingo told a news briefing.
Covaxin vaccine is an inactivated vaccine manufactured by Bharat Biotech.
The WHO had earlier accepted the Expression of Interest (EOI) for Covaxin from Bharat Biotech.
According to the data studied by the National drug regulator’s subject Expert committee, the vaccine is 77.8 percent effective in protecting against COVID-19.
Discussion about this post